The Risk of Long-term Morbidity and Mortality in Patients With Chronic Hepatitis C
Author(s) -
Jeffrey S. McCombs,
T. Matsuda,
Ivy Tonnu-Mihara,
Sammy Saab,
P. Hines,
Gilbert L’Italien,
Timothy Juday,
Yong Yuan
Publication year - 2013
Publication title -
jama internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.14
H-Index - 342
eISSN - 2168-6114
pISSN - 2168-6106
DOI - 10.1001/jamainternmed.2013.12505
Subject(s) - medicine , viral load , observational study , hepatitis c , cohort , proportional hazards model , medical record , viral hepatitis , veterans affairs , immunology , virus
The impact of viral load suppression, genotype, race, and other factors on the risk of late-stage liver-related events in patients with hepatitis C (HCV) has been assessed previously using data from small observational cohorts or clinical trials. Data from large real-world practice samples are needed to improve risk factor estimates for late-stage liver events and death in HCV.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom